(1888PressRelease)
June 27, 2008 - Gavin Choy, Vice President of Clinical Research Operations at SuperGen, Inc. will be speaking at GTCbio’s Global Clinical Trial Operations conference on September 25-26, 2008 in San Diego, CA. Dr. Choy will give a presentation entitled ADME in Phase 1 Clinical Trials.
Dr. Choy’s presentation at the conference will highlight the importance of pre-clinical ADME for Phase 1 studies and provide the importance of Phase 1 ADME for further development. He will also offer details on dose adjustments in special populations, along with Drug-Drug interactions.
The Global Clinical Trial Operations conference brings together leaders, directors, vice presidents, heads, managers, supervisors, and CROs from all over the world to collaborate and discuss the latest developments in clinical trial operations and logistics and covers clinical trials in emerging markets, first-in-man clinical trials, pediatric clinical trials, material storage, distribution, site selection, patient recruitment and retention, technology in clinical trials and case studies of running global clinical trials.
For more information including a detailed agenda, exhibitor opportunities and registration information visit http://gtcbio.com/conferenceDetails.aspx?id=127.
ABOUT GTCbio
GTCbio organizes conferences specifically for the biomedical and biopharmaceutical industries. Our goal is to facilitate the exchange of biopharmaceutical and biomedical intelligence between industry leaders, academic and government organizations, and the financial community. GTCbio is a subsidiary of Global Technology Community, LLC, a privately held company founded in 2002.
Contact: GTCBIO
434 W. Foothill Blvd.
Monrovia, CA 91016
Tel: (626) 256-6405
fax: (626) 256-6460
email: nina.tran ( @ ) gtcbio dot com
###
